SCHEMBL2812399

SCHEMBL2812399

c1ccc(N(c2ccc(-c3cn4ccccc4n3)cc2)c2ccc3c(c2)c2ccccc2n3-c2ccccc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 12/20 0.45
▸ NPC1 O15118 11/20 0.45
▸ KDM4E B2RXH2 10/20 0.45
▸ POLB P06746 1/20 0.45
▸ GFER P55789 3/20 0.44
▸ ALDH1A1 P00352 7/20 0.44
▸ SMN1; SMN2 Q16637 6/20 0.44
▸ MAPT P10636 3/20 0.44
▸ HTT P42858 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ PKM P14618 5/20 0.43
▸ MAPK1 P28482 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ MIF P14174 1/20 0.43
▸ HPGD P15428 2/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ NFKB2 Q00653 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13133743 0.97 RAB9A (0.44) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133738 0.96 RAB9A (0.44) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133731 0.93 RAB9A (0.44) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL2813623 0.92 RAB9A (0.50) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133736 0.92 RAB9A (0.44) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133742 0.92 RAB9A (0.41) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133745 0.92 RAB9A (0.41) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133734 0.91 RAB9A (0.47) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133757 0.91 RAB9A (0.39) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13133747 0.90 RAB9A (0.43) RAB9ANPC1KDM4EPOLBGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853403-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-10-07 — — US disclosed
US-8853403-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-10-07 — — US disclosed
US-8853403-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-10-07 — — US disclosed
US-20130130061-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-05-23 — — US disclosed
US-20130130061-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-05-23 — — US disclosed
US-20130130061-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-05-23 — — US disclosed
US-8329917-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-12-11 — — US disclosed
US-8329917-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-12-11 — — US disclosed
US-8329917-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-12-11 — — US disclosed
US-20100244670-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-09-30 — — US disclosed
US-20100244670-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-09-30 — — US disclosed
US-20100244670-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-09-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100244670-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same CRY1, LAGE3, NR2E3 RAB9A 1570/4885NPC1 4412/4885KDM4E 3699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback